abstract |
The present invention relates to derivatives of non-steroidal anti-inflammatory drugs (NSAIDs) that have improved anti-inflammatory properties, useful in the treatment of inflammation, pain and fever; more particularly, NSAIDs are derivatized with a portion that releases hydrogen sulfide (H2S) to produce novel anti-inflammatory compounds that have reduced side effects. |